Frailty: What Happens When We Are Too Late in Critical Lower Limb Ischemia

This condition, now “trending” among patients undergoing transcatheter aortic valve replacement (TAVR), has expanded to almost all patients we treat, always with the same outcome: the prognosis is bad, so bad that it might warrant making the difficult decision of not going forward. The association between frailty and bad prognosis is easy to see and derives from common sense; studies only provide figures. The difficult task here lies in its definition, since many aspects are quite subjective.

isquemia crítica de miembros inferioresThe results of this work are not surprising; they simply translate into statistics a reality we already imagined.

 

This study enrolled 643 patients with critical lower limb ischemia, among whom 486 were treated with endovascular therapy and 157 were treated with surgery. Each patient was assessed using a 9-level clinical frailty scale, and patients were divided into 3 groups: low (level 1-3, 213 patients), intermediate (level 4-6, 196 patients), and high (level 7-9, 213 patients) frailty. The follow-up period for these patients was 2 years.


Read also: HIV and Peripheral Artery Disease: Acknowledging the Association.


The survival rates in the low, intermediate, and high frailty groups were 80.5%, 63.1%, and 49.3%, respectively (p < 0.001). The amputation-free survival rates were 77.9 %, 60.5 %, and 46.2 %, respectively (p < 0.001).

 

In a multivariate analysis, higher frailty was independently associated with all-cause death and a composite of all-cause death and amputation. This association was observed in patients aged ≤75 as well as >75 years, both in those who underwent endovascular therapy or surgery, and in those with renal failure or normal kidney function.


Read also: MITRA-FR: Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation.


Frailty is here to stay and we will continue seeing it in our daily practice. However, the calculation of multiple scores is anything but practical and far from reality.

 

Conclusion

Frailty was independently associated with 2-year survival and major amputation in patients with critical lower limb ischemia regardless of age, revascularization type, or renal failure status.

 

Original title: Impact of Frailty on Clinical Outcomes in Patients with Critical Limb Ischemia.

Reference: Yasuaki Takeji et al. Circ Cardiovasc Interv. 2018;11:e006778.

 

2018-09-07e006778abierto.full


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...

IVUS-Guided vs. Angiography-Guided Drug-Coated Balloon Angioplasty in the Treatment of Femoropopliteal Lesions

Angiography has traditionally been the primary imaging technique for endovascular therapy guidance in patients with peripheral artery disease. However, as it only provides two-dimensional...

New Carotid PCI All-in-One System

Carotid stenting is equivalent to carotid endarterectomy in terms of major adverse events (death, AMI, and stroke). However, it entails higher risk of minor...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...